Concession Contract for Publishing, Selling and Marketing of the British Pharmacopoeia
MHRA
- Value
- £47,772,000
- Published
- 14 Sept 2026
- Deadline
- 29 Jan 2027
- Procedure
- Competitive flexible procedure
- Category
- 79970000 — Publishing services; 79342000 — Marketing services; 72413000 — World wide web (www) site design services
- Location
- UK, United Kingdom
- Notice reference
- 087063-2026
Requirements summary
The MHRA (Medicines and Healthcare products Regulatory Agency) is planning a concession contract for the publishing, selling and marketing of the British Pharmacopoeia, covering the 2029-2035 editions. The estimated value is GBP 39.81m net (GBP 47.772m gross), with a planned contract period from 31 March 2027 to 31 March 2032, extendable by two 12-month renewals to a maximum of 31 March 2034. The procurement uses a two-stage competitive flexible procedure with delivery across the UK.
Key requirements
- Publish, sell and market British Pharmacopoeia editions covering 2029-2035
- Concession contract with estimated value of GBP 39.81m net (GBP 47.772m gross)
- Contract period 31 March 2027 to 31 March 2032, with up to two 12-month renewals (maximum end 31 March 2034)
- Two-stage competitive flexible procedure; further details via pre-market engagement webinars
- Electronic submissions in English; tender period closes 29 January 2027
- Delivery across the United Kingdom; SME participation suitable